Literature DB >> 14702344

Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells.

Saswati Hazra1, Shigang Xiong, Jiaohong Wang, Richard A Rippe, V Krishna, K Chatterjee, Hidekazu Tsukamoto.   

Abstract

Depletion of peroxisome proliferator-activated receptor gamma (PPARgamma) accompanies myofibroblastic transdifferentiation of hepatic stellate cells (HSC), the primary cellular event underlying liver fibrogenesis. The treatment of activated HSC in vitro or in vivo with synthetic PPARgamma ligands suppresses the fibrogenic activity of HSC. However, it is uncertain whether PPARgamma is indeed a molecular target of this effect, because the ligands are also known to have receptor-independent actions. To test this question, the present study examined the effects of forced expression of PPARgamma via an adenoviral vector on morphologic and biochemical features of culture-activated HSC. The vector-mediated expression of PPARgamma itself is sufficient to reverse the morphology of activated HSC to the quiescent phenotype with retracted cytoplasm, prominent dendritic processes, reduced stress fibers, and accumulation of retinyl palmitate. These effects are abrogated by concomitant expression of a dominant negative mutant of PPARgamma that prevents transactivation of but not binding to the PPAR response element. PPARgamma expression also inhibits the activation markers such as the expression of alpha-smooth muscle actin, type I collagen, and transforming growth factor beta1; DNA synthesis; and JunD binding to the activator protein-1 (AP-1) site and AP-1 promoter activity. Inhibited JunD activity by PPARgamma is not due to reduced JunD expression or JNK activity or to a competition for p300. But it is due to a JunD-PPARgamma interaction as demonstrated by co-immunoprecipitation and glutathione S-transferase pull-down analysis. Further, the use of deletion constructs reveals that the DNA binding region of PPARgamma is the JunD interaction domain. In summary, our results demonstrate that the restoration of PPARgamma reverses the activated HSC to the quiescent phenotype and suppresses AP-1 activity via a physical interaction between PPARgamma and JunD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14702344     DOI: 10.1074/jbc.M310284200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  111 in total

1.  Daily genetic profiling indicates JAK/STAT signaling promotes early hepatic stellate cell transdifferentiation.

Authors:  Ashley M Lakner; Cathy C Moore; Alyssa A Gulledge; Laura W Schrum
Journal:  World J Gastroenterol       Date:  2010-10-28       Impact factor: 5.742

2.  New Approaches for Studying Alcoholic Liver Disease.

Authors:  Jun Xu; Xiao Liu; Bin Gao; Michael Karin; Hidekazu Tsukamoto; David Brenner; Tatiana Kisseleva
Journal:  Curr Pathobiol Rep       Date:  2014-09-14

3.  Transcriptional regulation of methionine adenosyltransferase 2A by peroxisome proliferator-activated receptors in rat hepatic stellate cells.

Authors:  Komal Ramani; Maria Lauda Tomasi
Journal:  Hepatology       Date:  2012-04-23       Impact factor: 17.425

4.  Morin, a plant derived flavonoid, modulates the expression of peroxisome proliferator-activated receptor-γ coactivator-1α mediated by AMPK pathway in hepatic stellate cells.

Authors:  Wei Yuan; Shoaib Ahmad; Ajaz Najar
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

5.  The iron chelator deferoxamine causes activated hepatic stellate cells to become quiescent and to undergo apoptosis.

Authors:  Haiyan Jin; Shuji Terai; Isao Sakaida
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

6.  Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation.

Authors:  Anna Baghdasaryan; Thierry Claudel; Astrid Kosters; Judith Gumhold; Dagmar Silbert; Andrea Thüringer; Katharina Leski; Peter Fickert; Saul J Karpen; Michael Trauner
Journal:  Gut       Date:  2010-04       Impact factor: 23.059

7.  Thiazolidinediones and hepatic fibrosis: don't wait too long.

Authors:  F Marra
Journal:  Gut       Date:  2006-07       Impact factor: 23.059

8.  Transgenic expression of an altered angiotensin type I AT1 receptor resulting in marked modulation of vascular type I collagen.

Authors:  Jun Yu; Linda Taylor; Celeste Rich; Paul Toselli; Philip Stone; Daniel Green; Rod Warburton; Nicholas Hill; Ronald Goldstein; Peter Polgar
Journal:  J Cell Physiol       Date:  2012-05       Impact factor: 6.384

9.  Nuclear receptor profile in calvarial bone cells undergoing osteogenic versus adipogenic differentiation.

Authors:  Flavia Q Pirih; Rosette Abayahoudian; David Elashoff; Farhad Parhami; Jeanne M Nervina; Sotirios Tetradis
Journal:  J Cell Biochem       Date:  2008-12-01       Impact factor: 4.429

10.  Activation of PPARgamma is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro.

Authors:  Shizhong Zheng; Anping Chen
Journal:  Biochem J       Date:  2004-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.